Should I Buy Alcoa Stock?
Alcoa (AA) finds itself in an interesting position in early…
Buy
60
GOOD Quote, Financials, Valuation and Earnings
Last price:
$15.10
Seasonality move
:
6.25%
Day range:
$14.82 - $15.07
52-week range:
$12.85 - $17.88
Dividend yield:
7.96%
P/E ratio:
55.81x
P/S ratio:
4.21x
P/B ratio:
3.89x
Volume:
293K
Avg. volume:
546.5K
1-year change:
10.56%
Market cap:
$666M
Revenue:
$149.4M
EPS (TTM):
$0.27
Analysts' Opinion
-
Consensus RatingGladstone Commercial has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 3 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $17.10, Gladstone Commercial has an estimated upside of 12.14% from its current price of $15.07.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $16.00 representing 100% downside risk from its current price of $15.07.
Fair Value
-
According to the consensus of 4 analysts, Gladstone Commercial has 12.14% upside to fair value with a price target of $17.10 per share.
GOOD vs. S&P 500
-
Over the past 5 trading days, Gladstone Commercial has overperformed the S&P 500 by 3.12% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Gladstone Commercial does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Gladstone Commercial has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Gladstone Commercial reported revenues of $37.4M.
Earnings Growth
-
Gladstone Commercial has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Gladstone Commercial reported earnings per share of $0.10.
Enterprise value:
1.3B
EV / Invested capital:
--
Price / LTM sales:
4.21x
EV / EBIT:
21.95x
EV / Revenue:
9.03x
PEG ratio (5yr expected):
-0.28x
EV / Free cash flow:
23.68x
Price / Operating cash flow:
11.05x
Enterprise value / EBITDA:
11.50x
Gross Profit (TTM):
$117.9M
Return On Assets:
2.17%
Net Income Margin (TTM):
16.07%
Return On Equity:
15.22%
Return On Invested Capital:
2.76%
Operating Margin:
35.69%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $149M | $147.6M | $149.4M | $35.9M | $37.4M | |
| Gross Profit | $115.8M | $115.3M | $117.9M | $28.8M | $28.8M | |
| Operating Income | $44.8M | $50.8M | $51.1M | $13.5M | $13.3M | |
| EBITDA | $103.4M | $100.1M | $117.2M | $27.8M | $29.4M | |
| Diluted EPS | -$0.04 | -$0.19 | $0.27 | $0.04 | $0.10 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $33.7M | $20.5M | $28.1M | $52.4M | $43.4M | |
| Total Assets | $1.1B | $1.1B | $1.2B | $1.1B | $1.1B | |
| Current Liabilities | $81.4M | $70.5M | $76.2M | $121.9M | $39.6M | |
| Total Liabilities | $881.9M | $940.8M | $996.9M | $979.2M | $923M | |
| Total Equity | $216M | $202.6M | $205.7M | $154.3M | $171.3M | |
| Total Debt | $668.7M | $707.5M | $749.2M | $738.9M | $693.4M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $69.2M | $60.4M | $57M | $11.9M | $22.8M | |
| Cash From Investing | -$82.5M | $1.1M | -$1.7M | $4.7M | -$10.4M | |
| Cash From Financing | $16.2M | -$61.4M | -$56.3M | -$22.5M | -$11.9M | |
| Free Cash Flow | $69.2M | $60.4M | $57M | $11.9M | $22.8M | |
GOOD
Sector
Market Cap
$666M
$1B
Price % of 52-Week High
84.31%
81.04%
Dividend Yield
7.96%
3.28%
Shareholder Yield
1.19%
3.41%
1-Year Price Total Return
10.57%
-1.87%
Beta (5-Year)
1.174
0.770
Dividend yield:
7.96%
Annualized payout:
$1.20
Payout ratio:
261.6%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$14.89
200-day SMA
Sell
Level
$15.65
Bollinger Bands (100)
Sell
Level
15.44 - 16.94
Chaikin Money Flow
Buy
Level
672K
20-day SMA
Sell
Level
$15.07
Relative Strength Index (RSI14)
Sell
Level
45.06
ADX Line
Sell
Level
34.53
Williams %R
Sell
Level
-13.1169
50-day SMA
Sell
Level
$15.72
MACD (12, 26)
Sell
Level
-0.24
25-day Aroon Oscillator
Sell
Level
-56
On Balance Volume
Neutral
Level
4.9M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-0.0079)
Sell
CA Score
(Annual)
Level (-1.7915)
Buy
Beneish M-Score
(Annual)
Level (-3.5127)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (2.142)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (2)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Gladstone Commercial Corp is a real estate investment trust, which engages in investing and owning net leased industrial, commercial, and retail real property and making long-term industrial and commercial mortgage loans. Its portfolio consists of single-tenant commercial, industrial real properties, and medical properties nationwide. Its principal investment objectives are to generate income from rental properties.
Stock Forecast FAQ
In the current month, GOOD has received 1 Buy ratings 3 Hold ratings, and 0 Sell ratings. The GOOD average analyst price target in the past 3 months is $17.10.
-
Where Will Gladstone Commercial Stock Be In 1 Year?
According to analysts, the consensus estimate is that Gladstone Commercial share price will rise to $17.10 per share over the next 12 months.
-
What Do Analysts Say About Gladstone Commercial?
Analysts are divided on their view about Gladstone Commercial share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Gladstone Commercial is a Sell and believe this share price will drop from its current level to $16.00.
-
What Is Gladstone Commercial's Price Target?
The price target for Gladstone Commercial over the next 1-year time period is forecast to be $17.10 according to 4 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.
-
Is GOOD A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Gladstone Commercial is a Hold. 3 of 4 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of GOOD?
You can purchase shares of Gladstone Commercial via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Gladstone Commercial shares.
-
What Is The Gladstone Commercial Share Price Today?
Gladstone Commercial was last trading at $15.10 per share. This represents the most recent stock quote for Gladstone Commercial. Yesterday, Gladstone Commercial closed at $15.07 per share.
-
How To Buy Gladstone Commercial Stock Online?
In order to purchase Gladstone Commercial stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Nu Holdings Stock Be in 2030?
Despite fast growth, high profitability and an extraordinary runway ahead,…
Is it Too Late to Buy United Airlines Stock?
United Airlines (NASDAQ:UAL) has thoroughly outpaced the broader stock market…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 37x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
42
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
78
GATE alert for Apr 2
Marblegate Acquisition [GATE] is up 86.64% over the past day.
Buy
52
NUTX alert for Apr 2
Nutex Health [NUTX] is up 5.41% over the past day.
Buy
75
CORT alert for Apr 2
Corcept Therapeutics [CORT] is down 8.84% over the past day.
